Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» September 2011
September 2011
Calif. AG won't review finding in Medicis CEO girlfriend's death
Calif. AG won't review finding in Medicis CEO girlfriend's death
Yahoo/AP
Medicis
Jonah Shacknai
ImmunoGen advances lymphoma drug candidate
ImmunoGen advances lymphoma drug candidate
Bizjournals.com
Immunogen
IMGN529
chronic lymphocytic leukemia
non-Hodgkin's lymphoma
Celgene's Revlimid Passes EU Safety Review
Celgene's Revlimid Passes EU Safety Review
TheStreet.com
Celgene
Revlimid
Europe
EU
Multiple Myeloma
J&J Recall Watch: Eprex Anemia Drug Pulled on Potency Worries
J&J Recall Watch: Eprex Anemia Drug Pulled on Potency Worries
WSJ Online
Eprex
anemia
recalls
JNJ
Europe Calls for Limits on Sanofi's Multaq
Europe Calls for Limits on Sanofi's Multaq
Motley Fool
Sanofi
Multaq
Europe
EMA
Bristol CEO says "pure pharma" strategy paying off
Bristol CEO says "pure pharma" strategy paying off
Reuters
Bristol-Myers Squibb
Pharma CEOs
Lamberto Andreotti
PharmAthene Wins Rights to Profit From Siga Smallpox Drug
PharmAthene Wins Rights to Profit From Siga Smallpox Drug
Bloomberg
PharmAthene
smallpox
SIGA technologies
ST-246
Could Merck Be Hiding Weakness?
Could Merck Be Hiding Weakness?
Motley Fool
Merck
Bayer’s Xarelto Wins EU Drug Panel Backing for Added Use
Bayer’s Xarelto Wins EU Drug Panel Backing for Added Use
Bloomberg
Bayer
bloodthinners
Xarelto
Europe
Bristol pays $24M for early-stage biotech drugs
Bristol pays $24M for early-stage biotech drugs
Yahoo/AP
Bristol-Myers Squibb
Ambrx
Relaxin
fibroblast activation protein
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »